echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JNNP: GBA gene mutation affects the cognitive status of patients with amyotrophic lateral sclerosis

    JNNP: GBA gene mutation affects the cognitive status of patients with amyotrophic lateral sclerosis

    • Last Update: 2021-10-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Amyotrophic lateral sclerosis (ALS) is a continuous degeneration of upper and lower motor neurons


    According to reports, several genes can cause ALS and FTD


    The GBA gene encodes glucocerebrosidase (GCase), a lysosomal enzyme that converts glucocerebrosides into glucose and ceramide


    This article was published in the " Journal of Neurology, Neurosurgery & Psychiatry " ( Journal of Neurology, Neurosurgery & Psychiatry )


    A study on the correlation between GBA variants and the risk of cognitive impairment was conducted on 751 patients with ALS, and they received detailed neuropsychological evaluation and whole-genome sequencing screening


    A study on the correlation between GBA variants and the risk of cognitive impairment was conducted on 751 patients with ALS, and they received detailed neuropsychological evaluation and whole-genome sequencing screening


    First, use a binomial test to assess the prevalence of GBA mutations in patients with cognitive decline.


    Cognitive phenotype frequency of GBA risk variant carriers

    A GBA mutation known to cause Gaucher disease in homozygous carriers, a possible pathogenic variant (p.


    A GBA mutation known to cause Gaucher disease in homozygous carriers, a possible pathogenic variant (p.


    It has been observed that the burden of rare variants in the GBA gene is associated with cognitive impairment in patients with ALS


    In summary, this article found that GBA gene mutations are associated with an increased risk of cognitive impairment in ALS patients


    The results of the study broaden the range of genetic factors that regulate the susceptibility of cognitive dysfunction in ALS patients, and strengthen the role of lysosomal damage in the potential neurodegeneration of ALS, emphasizing that genes can not only change the risk of ALS, but can also regulate Research results on different aspects of its phenotype broaden the range of genetic factors that regulate the susceptibility of cognitive dysfunction in ALS patients, and strengthen the role of lysosomal damage in the potential neurodegenerative process of ALS, emphasizing that genes can not only change ALS It can also regulate different aspects of its phenotype anosaA ,GrassanoM ,MogliaC anosa  A anosa Grassano  M Grassano Moglia  C Moglia , et al GBA variants influence cognitive status in amyotrophic lateral sclerosis Journal of Neurology, Neurosurgery & Psychiatry  Published Online First:  28 September 2021.
      Published Online First: doi:  10.
    1136/jnnp-2021-327426 doi:

    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.